Nanmo Biotech announced on August 14 that the company intends to participate as a limited partner in the establishment of the Yancheng Market Scene Innovation and Application Industry Investment Fund partnership. The total size of the Yancheng Scenario Venture Capital Fund is 300 million yuan. It mainly invests in the artificial intelligence and biomedical industries in Yancheng City. The company plans to pledge an investment of 59 million yuan with its own capital. After the investment is completed, it will hold about 19.67% of the property share of the Yancheng Scenario Venture Capital Fund.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.